Influenza A H1N1 Community-Acquired Pneumonia: Characteristics and Risk Factors-A Case-Control Study.
Journal
Canadian respiratory journal
ISSN: 1916-7245
Titre abrégé: Can Respir J
Pays: Egypt
ID NLM: 9433332
Informations de publication
Date de publication:
2019
2019
Historique:
received:
18
12
2018
revised:
06
02
2019
accepted:
19
02
2019
entrez:
23
4
2019
pubmed:
23
4
2019
medline:
4
12
2019
Statut:
epublish
Résumé
Influenza A H1N1 community-acquired pneumonia (CAP) is a quite frequent respiratory disease. Despite being considered more serious than other CAPs, there are very few studies comparing its characteristics with noninfluenza CAP. We aim to establish the differences between pneumonia due to H1N1 virus and pneumonia not caused by H1N1 influenza virus and to determine the probability that a pneumonia is due to an H1N1 virus infection based on the most relevant variables. We used a case-control study where cases were H1N1 CAP patients with confirmed microbiological diagnosis and controls were patients with CAP admitted to hospital. H1N1 and other influenza types were discarded among controls. We calculated the probability of being a case or control using multivariate logistic regression. We included 99 cases and 270 controls. Cases were younger than controls (53 vs 71 years, respectively). Mortality was much higher for H1N1 patients (13% vs 0.3%), and admission to intensive care unit was more frequent for H1N1 cases. The variables most associated with presenting H1N1 CAP were bilateral affectation on chest X-rays (OR: 5.70; 95% CI 2.69-10.40), followed by presence of arthromyalgias, with cases presenting close to three times more arthromyalgias compared to controls. Low leukocytes count and high AST values were also significantly associated with H1N1 CAP. H1N1 CAPs are characterized by bilateral affectation, low leukocyte count, presence of arthromyalgias, and high AST. A few and easy to obtain clinical parameters might be extremely useful to distinguish H1N1 CAP from CAPs of other origin.
Identifiants
pubmed: 31007805
doi: 10.1155/2019/4301039
pmc: PMC6441515
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
4301039Références
Arch Bronconeumol. 2010 Oct;46(10):543-58
pubmed: 20832928
Clin Infect Dis. 2007 Mar 1;44 Suppl 2:S27-72
pubmed: 17278083
Afr Health Sci. 2015 Jun;15(2):352-9
pubmed: 26124779
Rev Invest Clin. 2016 Sep-Oct;68(5):235-244
pubmed: 27941959
Acad Emerg Med. 2013 Jan;20(1):46-53
pubmed: 23570478
Scand J Infect Dis. 2011 Jan;43(1):19-26
pubmed: 20925450
Eur J Radiol. 2015 Sep;84(9):1810-5
pubmed: 26163993
PLoS One. 2010 Mar 05;5(3):e9563
pubmed: 20221431
J Infect. 2012 Sep;65(3):223-30
pubmed: 22543245
Eur Respir J. 2011 Jul;38(1):106-11
pubmed: 21109555
AJR Am J Roentgenol. 2009 Dec;193(6):1488-93
pubmed: 19933638
J Hosp Infect. 2017 Feb;95(2):200-206
pubmed: 28153560
PLoS One. 2010 Sep 21;5(9):e12849
pubmed: 20877727
N Engl J Med. 2009 Jun 18;360(25):2605-15
pubmed: 19423869
N Engl J Med. 1997 Jan 23;336(4):243-50
pubmed: 8995086
PLoS One. 2012;7(10):e46816
pubmed: 23071646
N Engl J Med. 2009 Aug 13;361(7):680-9
pubmed: 19564631
Respir Med. 2011 Sep;105(9):1404-11
pubmed: 21561754
Int J Infect Dis. 2011 Jul;15(7):e470-4
pubmed: 21601504
Monaldi Arch Chest Dis. 2012 Sep-Dec;77(3-4):118-21
pubmed: 23461247
Crit Care. 2009;13(5):R148
pubmed: 19747383
Clin Microbiol Infect. 2012 Oct;18(10):1040-8
pubmed: 22264290
Thorax. 2009 Oct;64 Suppl 3:iii1-55
pubmed: 19783532
JAMA. 1996 Jan 10;275(2):134-41
pubmed: 8531309
JAMA. 2009 Nov 4;302(17):1872-9
pubmed: 19822627
Clin Infect Dis. 2009 Feb 15;48(4):377-85
pubmed: 19140759
Biomed Rep. 2013 Sep;1(5):723-726
pubmed: 24649017
Respir Investig. 2014 Sep;52(5):280-7
pubmed: 25169843